Inspire Medical Systems (INSP) Net Cash Flow (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Net Cash Flow data on file, last reported at -$5.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 93.87% year-over-year to -$5.9 million; the trailing twelve-month figure through Mar 2026 stood at $45.1 million (up 137.16% YoY), and the FY2025 full-year result was -$45.0 million, down 27.67% from the prior year.
• Net Cash Flow rose to -$5.9 million in Q1 2026, from -$7.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $231.4 million in Q3 2022 to a low of -$144.6 million in Q4 2023.
• A 5-year average of -$6.8 million and a median of -$5.9 million in 2026 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow soared 587.48% in 2022 and sank 1955.24% in 2024, its largest moves.
• Tracing INSP's Net Cash Flow over 5 years: stood at $23.6 million in 2022, then sank by 712.38% to -$144.6 million in 2023, then surged by 101.94% to $2.8 million in 2024, then slumped by 376.64% to -$7.8 million in 2025, then grew by 24.17% to -$5.9 million in 2026.
• Business Quant data shows INSP's Net Cash Flow at -$5.9 million in Q1 2026, -$7.8 million in Q4 2025, and $5.8 million in Q3 2025.